Grace Larry

Director/Board Member at Generate Biomedicines, Inc.

Consumer Services

Health Technology

Finance

Profile

Grace Larry is currently a Senior Director at Generate Biomedicines, Inc. and a Venture Partner at Alix Ventures.
Prior to his current roles, he worked as an Executive Director at Amgen, Inc. from 2019 to 2021 and as a Director-Asia Operations at Novartis AG from 2011 to 2013.
Mr. Larry has a graduate degree from the University of California, Berkeley, an MBA from Kellogg School of Management, and a graduate degree from Northwestern University School of Law.

Grace Larry active positions

Companies	Position	Start
Alix Ventures Alix Ventures Investment ManagersFinance Alix Ventures is an venture capital firm founded in 2019 by Chas Pulido. The firm is headquartered in San Francisco, California.	Private Equity Investor	-
Generate Biomedicines, Inc. Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018.	Director/Board Member	01/07/2021

All active positions of Grace Larry

Former positions of Grace Larry

Companies	Position	End
AMGEN INC.	Director/Board Member	01/04/2021
NOVARTIS AG	Corporate Officer/Principal	01/04/2013

See the detail of Grace Larry's experience

Training of Grace Larry

Northwestern University School of Law	Graduate Degree
Kellogg School of Management	Masters Business Admin
University of California, Berkeley	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Grace Larry's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
AMGEN INC.	Health Technology
NOVARTIS AG	Health Technology

Private companies	2
Alix Ventures Alix Ventures Investment ManagersFinance Alix Ventures is an venture capital firm founded in 2019 by Chas Pulido. The firm is headquartered in San Francisco, California.	Finance
Generate Biomedicines, Inc. Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018.	Health Technology